Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

49

Revenue 2017

Janumet

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Janumet was produced by Merck & Co..

Merck pulls Keytruda filing in Europe, despite US approval

Merck pulls Keytruda filing in Europe, despite US approval

portfolio after its Januvia/Janumet diabetes franchise.

FDA won't add outcomes data to Januvia label

FDA won't add outcomes data to Januvia label The US regulator has sent the pharma company a complete response letter for DPP-4 inhibitor Januvia (sitagliptin) and combination product Janumet (sitagliptin plus metformin) - along with extended release formulations - saying

Merck drops once-weekly diabetes drug in US and EU

Merck drops once-weekly diabetes drug in US and EU Januvia and companion drug Janumet (sitagliptin plus metformin) brought in revenues of just over $6bn last year, in line with 2014, and the once-buoyant growth of the franchise has been

Dr Susanne Fiedler takes over as CEO of MSD Germany

Dr Susanne Fiedler takes over as CEO of MSD Germany Since then Dr Fielder has served in the US, where MSD operates at Merck &Co, as global brand leader for the diabetes treatments Januvia and Janumet, before taking up a

BMS pulls ahead of Merck in quarterly PD-1 inhibitor sales

BMS pulls ahead of Merck in quarterly PD-1 inhibitor sales Merck meanwhile posted revenues of $10.07bn, a 2% increase, with its Januvia (sitagliptin) and Janumet (sitagliptin and metformin) diabetes franchise leading the charge with sales 9% to $1.01bn and

1 2 3 4 5 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics